1. Home
  2. ALT vs AVNW Comparison

ALT vs AVNW Comparison

Compare ALT & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • AVNW
  • Stock Information
  • Founded
  • ALT 1997
  • AVNW 2006
  • Country
  • ALT United States
  • AVNW United States
  • Employees
  • ALT N/A
  • AVNW N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • AVNW Radio And Television Broadcasting And Communications Equipment
  • Sector
  • ALT Health Care
  • AVNW Technology
  • Exchange
  • ALT Nasdaq
  • AVNW Nasdaq
  • Market Cap
  • ALT 327.4M
  • AVNW 274.4M
  • IPO Year
  • ALT N/A
  • AVNW 2007
  • Fundamental
  • Price
  • ALT $3.87
  • AVNW $24.21
  • Analyst Decision
  • ALT Strong Buy
  • AVNW Strong Buy
  • Analyst Count
  • ALT 6
  • AVNW 4
  • Target Price
  • ALT $17.40
  • AVNW $36.50
  • AVG Volume (30 Days)
  • ALT 2.5M
  • AVNW 127.6K
  • Earning Date
  • ALT 11-11-2025
  • AVNW 09-10-2025
  • Dividend Yield
  • ALT N/A
  • AVNW N/A
  • EPS Growth
  • ALT N/A
  • AVNW N/A
  • EPS
  • ALT N/A
  • AVNW 0.10
  • Revenue
  • ALT $20,000.00
  • AVNW $434,606,000.00
  • Revenue This Year
  • ALT N/A
  • AVNW $6.43
  • Revenue Next Year
  • ALT $761,880.20
  • AVNW $7.33
  • P/E Ratio
  • ALT N/A
  • AVNW $241.40
  • Revenue Growth
  • ALT N/A
  • AVNW 6.50
  • 52 Week Low
  • ALT $2.90
  • AVNW $12.96
  • 52 Week High
  • ALT $11.16
  • AVNW $26.83
  • Technical
  • Relative Strength Index (RSI)
  • ALT 55.49
  • AVNW 57.43
  • Support Level
  • ALT $3.56
  • AVNW $23.26
  • Resistance Level
  • ALT $3.72
  • AVNW $24.55
  • Average True Range (ATR)
  • ALT 0.18
  • AVNW 1.02
  • MACD
  • ALT 0.03
  • AVNW 0.14
  • Stochastic Oscillator
  • ALT 51.15
  • AVNW 56.13

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About AVNW Aviat Networks Inc.

Aviat Networks Inc is a networking solutions provider. It designs, manufactures and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.

Share on Social Networks: